Cladis Investment Advisory, LLC Gsk PLC Transaction History

Cladis Investment Advisory, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Oct 09, 2024	BUY	$42.05 - $47.77 $323,785 - $367,829	7,700 New	7,700 $335 Million
Q2 2022 Aug 09, 2022	SELL	$42.05 - $47.77 $42,050 - $47,770	-1,000 Reduced 11.49%	7,700 $335,000
Q1 2022 Oct 08, 2024	BUY	$40.23 - $47.74 $40,230 - $47,740	1,000 Added 12.99%	8,700 $379 Million
Q1 2022 May 10, 2022	BUY	$40.23 - $47.74 $40,230 - $47,740	1,000 Added 12.99%	8,700 $379,000
Q4 2021 Oct 08, 2024	BUY	$38.88 - $45.31 $299,376 - $348,887	7,700 New	7,700 $340 Million
Q4 2021 Oct 01, 2024	BUY	$38.88 - $45.31 $299,376 - $348,887	7,700 New	7,700 $340 Million
Q4 2021 May 10, 2022	BUY	$38.88 - $45.31 $299,376 - $348,887	7,700 New	7,700 $340,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Cladis Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Cladis Investment Advisory, LLC with notifications on news.